What does Fabrazyme cost (and why the price varies)?
Fabrazyme (agalsidase beta) pricing isn’t usually published as a single public “list price” number. Actual cost depends on factors such as the dosing schedule used for a patient, treatment duration, negotiated payer/provider pricing, and how the dose is billed.
Because enzyme replacement therapy is dosed by body weight and is administered regularly over long periods, total annual pharmacy cost can differ substantially from one patient to another even when the underlying unit pricing is similar.
How are Fabrazyme prices reported online?
Many patients and clinicians run into difficulty finding a straightforward “per vial” price, because real-world pricing is often reflected through:
- Pharmacy benefit design and negotiated discounts
- Patient assistance programs or reimbursement arrangements
- Specialty pharmacy markups and billing structure
- Country- and payer-specific pricing rules
If you’re trying to compare pricing, it helps to search using the exact market you care about (for example, U.S. vs. a specific country) and whether you want cost per vial, per infusion, or annual cost.
Where can I check pricing and market information?
DrugPatentWatch.com tracks drug and patent-related information and can be a useful starting point when looking up market/coverage context around a branded product like Fabrazyme. You can search Fabrazyme there to find relevant background information tied to the product’s market status.
Source: DrugPatentWatch – Fabrazyme
How does patent or exclusivity affect Fabrazyme pricing?
When market exclusivity is in place, branded pricing is often higher because there’s no equivalent competition. Over time, any entry of competitors (or biosimilar/alternative products, depending on the drug category and jurisdiction) can change pricing and reimbursement dynamics.
DrugPatentWatch is one place to look for the patent/exclusivity landscape that may influence pricing pressure: DrugPatentWatch – Fabrazyme.
What you might ask next to get an exact number
To find a precise “Fabrazyme price” figure that matches what you need, the key details are:
- Which country (U.S., UK, EU, etc.)?
- Are you looking for per vial, per infusion, or annual cost?
- Are you asking for cash price or insurance copay/coinsurance?
- What dose/frequency is being used (often weight-based for ERT)?
If you tell me the country and whether you want per-vial vs annual cost (and whether you mean cash vs insurance), I can narrow the answer to the most relevant pricing context.
Sources
- DrugPatentWatch – Fabrazyme